Skip to main content
. 2017 Apr 21;23(15):2771–2784. doi: 10.3748/wjg.v23.i15.2771

Figure 9.

Figure 9

Receiver operating characteristic curves for 3-indoleacetic acid, indoleacetic acid, L-carnitine, and pyroglutamic acid in the non-alcoholic steatohepatitis and non-alcoholic fatty liver disease groups. NAFLD: Non-alcoholic fatty liver disease; NASH: Non-alcoholic steatohepatitis.